Chemopreventive and therapeutic effects of nimbolide in cancer: The underlying mechanisms

Toxicology in Vitro

Volumn 28, Issue 5, 2014, Pages 1026-1035

  Bodduluru, Lakshmi Narendra ^a   Kasala, Eshvendar Reddy ^a   Thota, Nagaraju ^a   Barua, Chandana C ^b   Sistla, Ramakrishna ^c  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b ASSAM AGRICULTURAL UNIVERSITY   (India)

^c INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Apoptosis; Cancer; Chemoprevention; NF B; Nimbolide

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NIMBOLIDE; ANTINEOPLASTIC AGENT; LIMONOID;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; CANCER INHIBITION; CANCER PREVENTION; CLINICAL EFFECTIVENESS; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; ENZYME ACTIVATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR DYNAMICS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; NEOPLASMS; TOXICITY;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; HUMANS; LIMONINS; NEOPLASMS;

EID: 84901048929     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.04.011     Document Type: Review

References (64)

1. Arora N., Koul A., Bansal M.P. Chemopreventive activity of Azadirachta indica on two-stage skin carcinogenesis in murine model. Phytother. Res. 2011, 25:408-416.
2. Babykutty S., Ps P., Rj N., Kumar M.A., Nair M.S., Srinivas P., Gopala S. Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP-2/9 expression via inhibiting ERK1/2 and reducing DNA-binding activity of NF-KB in colon cancer cells. Mol. Carcinog. 2012, 51:475-490.
3. Balasenthil S., Arivazhagan S., Ramachandran C.R., Ramachandran V., Nagini S. Chemopreventive potential of neem (Azadirachta indica) on 7,12-dimethylbenz [a] anthracene (DMBA) induced hamster buccal pouch carcinogenesis. J. Ethnopharmacol. 1999, 67:189-195.
4. Baral R., Chattopadhyay U. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma. Int. Immunopharmacol. 2004, 4:355-366.
5. Bharati S., Rishi P., Koul A. Azadirachta indica exhibits chemopreventive action against hepatic cancer: studies on associated histopathological and ultrastructural changes. Microsc. Res. Tech. 2012, 75:586-595.
6. Biswas K., Chattopadhyay I., Banerjee R.K., Bandyopadhyay U. Biological activities and medicinal properties of neem (Azadirachta indica). Curr. Sci. 2002, 82:1336-1345.
7. Chaturvedi M.M., Sung B., Yadav V.R., Kannappan R., Aggarwal B.B. NF-KB addiction and its role in cancer: 'one size does not fit all'. Oncogene 2011, 30:1615-1630.
8. Chen J., Chen J., Sun Y., Yan Y., Kong L., Li Y., Qiu M. Cytotoxic triterpenoids from Azadirachta indica. Planta Med. 2011, 77:1844-1847.
9. Cohen E., Quistad G.B., Casida J.E. Cytotoxicity of nimbolide, epoxyazadiradione and other limonoids from neem insecticide. Life Sci. 1996, 58:1075-1081.
10. Dasgupta T., Banerjee S., Yadava P.K., Rao A.R. Chemopreventive potential of Azadirachta indica (Neem) leaf extract in murine carcinogenesis model systems. J. Ethnopharmacol. 2004, 92:23-36.
11. Dreesen O., Brivanlou A.H. Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev. 2007, 3:7-17.
12. Du Q., Geller D.A. Cross-regulation between Wnt and NF-KB signaling pathways. Forum Immunopathol. Disea. Ther. 2010, 1:155-181.
13. Elumalai P., Gunadharini D.N., Senthilkumar K., Banudevi S., Arunkumar R., Benson C.S., Sharmila G., Arunakaran J. Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway. Toxicol. Lett. 2012, 215:131-142.
14. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 127:2893-2917.
15. Gangar S.C., Sandhir R., Rai D.V., Koul A. Modulatory effects of Azadirachta indica on benzo (a) pyrene-induced forestomach tumorigenesis in mice. World J. Gastroenterol. 2006, 12:2749-2755.
16. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr.
17. Gupta S.C., Prasad S., Reuter S., Kannappan R., Yadav V.R., Ravindran J., Hema P.S., Chaturvedi M.M., Nair M., Aggarwal B.B. Modification of cysteine 179 of IkBa kinase by nimbolide leads to down-regulation of NF-kB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents. J. Biol. Chem. 2010, 285:35406-35417.
18. Subash C., Gupta S.P., Simone Reuter, Ramaswamy Kannappan, Yadav Vivek R., Jayaraj Ravindran, Padmanabhan S., Hema M.M.C., Mangalam Nair, Aggarwal Bharat B. Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent upregulation of death receptors, p53, and Bax. The J. Biol. Chem. 2011, 286:1134-1146.
19. Gupta S., Prasad S., Sethumadhavan D.R., Nair M.S., Mo Y.-Y., Aggarwal B.B. Nimbolide, a limonoid triterpene, inhibits growth of human colorectal cancer xenografts by suppressing the proinflammatory microenvironment. Clin. Cancer Res. 2013, 19:4465-4476.
20. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
21. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
22. Hasima N., Aggarwal B.B. Cancer-linked targets modulated by curcumin. Int. J. Biochem. Molec. Biol. 2012, 3:328-351.
23. Hursting S.D., Slaga T.J., Fischer S.M., DiGiovanni J., Phang J.M. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J. Natl Cancer Inst. 1999, 91:215-225.
24. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
25. Karkare S., Chhipa R.R., Liu X., Henry H., Gasilina A., Nassar N., Pauletti G.M., Ghosh P.K., Dasgupta B., Roychoudhury J. Direct inhibition of retinoblastoma phosphorylation by nimbolide causes cell cycle arrest and suppresses glioblastoma growth. Clin. Cancer Res. 2013, 10.1158/1078-0432.CCR-13-0762.
26. Kavitha K., Vidya Priyadarsini R., Anitha P., Ramalingam K., Sakthivel R., Purushothaman G., Singh A.K., Karunagaran D., Nagini S. Nimbolide, a neem limonoid abrogates canonical NF-KB and Wnt signaling to induce caspase-dependent apoptosis in human hepatocarcinoma (HepG2) cells. Eur. J. Pharmacol. 2012, 681:6-14.
27. Kigodi P.G.K., Blaska G.b., Thebtaranonth Y., Pezzuto J.M., Cordell G.A. Spectroscopic and biological investigation of nimbolide and 28-deoxonimbolide from Azadirachta indica. J. Natl. Prod. 1989, 52:1246-1251.
28. Koul A., Mukherjee N., Gangar S.C. Inhibitory effects of Azadirachta indica on DMBA-induced skin carcinogenesis in Balb/c mice. Mol. Cell. Biochem. 2006, 283:47-55.
29. Kumar G.H., Mohan K.V.P.C., Rao A.J., Nagini S. Nimbolide a limonoid from Azadirachta indica inhibits proliferation and induces apoptosis of human choriocarcinoma (BeWo) cells. Invest. New Drugs 2009, 27:246-252.
30. Kumar G.H., Priyadarsini R.V., Vinothini G., Letchoumy P.V., Nagini S. The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis. Invest. New Drugs 2010, 28:392-401.
31. Lowe S.W., Lin A.W. Apoptosis in cancer. Carcinogenesis 2000, 21:485-495.
32. Madan E., Prasad S., Roy P., George J., Shukla Y. Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells. Biochem. Biophys. Res. Commun. 2008, 377:1232-1237.
33. Mahapatra S., Young C.Y.F., Kohli M., Karnes R.J., Klee E.W., Holmes M.W., Tindall D.J., Donkena K.V. Antiangiogenic effects and therapeutic targets of Azadirachta indica leaf extract in endothelial cells. Evid. Based Complement. Alternat. Med. 2012, 10.1155/2012/303019.
34. Manoharan S., Rajmani Ramachandran C., Ramachandran V., Nagini S. Inhibition of 4-nitroquinoline-1-oxide-induced oral carcinogenesis by plant products. J. Clin. Biochem. Nutr. 1996, 21:141-149.
35. Mohan K.V.P., Gunasekaran P., Varalakshmi E., Hara Y., Nagini S. In vitro evaluation of the anticancer effect of lactoferrin and tea polyphenol combination on oral carcinoma cells. Cell Biol. Int. 2007, 31:599-608.
36. Paul R., Prasad M., Sah N.K. Anticancer biology of Azadirachta indica L (neem): a mini review. Cancer Biol. Ther. 2011, 12:467-476.
37. Plati J., Bucur O., Khosravi-Far R. Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities. J. Cell. Biochem. 2008, 104:1124-1149.
38. Priyadarsini R.V., Manikandan P., Kumar G.H., Nagini S. The neem limonoids azadirachtin and nimbolide inhibit hamster cheek pouch carcinogenesis by modulating xenobiotic-metabolizing enzymes, DNA damage, antioxidants, invasion and angiogenesis. Free Radical Res. 2009, 43:492-504.
39. Priyadarsini R.V., Murugan R.S., Sripriya P., Karunagaran D., Nagini S. The neem limonoids azadirachtin and nimbolide induce cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells. Free Radical Res. 2010, 44:624-634.
40. Raja Singh P., Arunkumar R., Sivakamasundari V., Sharmila G., Elumalai P., Suganthapriya E., Brindha Mercy A., Senthilkumar K., Arunakaran J. Anti-proliferative and apoptosis inducing effect of nimbolide by altering molecules involved in apoptosis and IGF signalling via PI3K/Akt in prostate cancer (PC-3) cell line. Cell Biochem. Funct. 2013, 10.1002/cbf.2993.
41. Reed J.C. Mechanisms of apoptosis avoidance in cancer. Curr. Opin. Oncol. 1999, 11:68-75.
42. Rochanakij S., Thebtaranonth Y., Yuthavong Y. Nimbolide, a constituent of Azadirachta indica, inhibits Plasmodium falciparum in culture. Southeast Asian J. Trop. Med. Public Health 1985, 16:66-72.
43. Roy M.K., Kobori M., Takenaka M., Nakahara K., Shinmoto H., Tsushida T. Inhibition of colon cancer (HT-29) cell proliferation by a triterpenoid isolated from Azadirachta indica is accompanied by cell cycle arrest and up-regulation of p21. Planta Med. 2006, 72:917-923.
44. Roy M.K., Kobori M., Takenaka M., Nakahara K., Shinmoto H., Isobe S., Tsushida T. Antiproliferative effect on human cancer cell lines after treatment with nimbolide extracted from an edible part of the neem tree (Azadirachta indica). Phytother. Res. 2007, 21:245-250.
45. Sastry B.S., Suresh Babu K., Hari Babu T., Chandrasekhar S., Srinivas P.V., Saxena A.K., Madhusudana Rao J. Synthesis and biological activity of amide derivatives of nimbolide. Bioorg. Med. Chem. Lett. 2006, 16:4391-4394.
46. Shen H.-M., Tergaonkar V. NFKB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis 2009, 14:348-363.
47. Singh S.R. Cancer stem cells: recent developments and future prospects. Cancer Lett. 2013, 338:1-2.
48. Sporn M.B., Dunlop N.M., Newton D.L., Smith J.M. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Federation Proc. 1976, 35:1332-1338.
49. Sritanaudomchai H., Kusamran T., Kuakulkiat W., Bunyapraphatsara N., Hiransalee A., Tepsuwan A., Kursamran W. Quinone reductase inducers in Azadirachta indica A. Juss flowers, and their mechanisms of action. Asian Pac. J. Cancer Prev. 2005, 6:263-269.
50. Subapriya R., Nagini S. Ethanolic neem leaf extract protects against N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in Wistar rats. Asian Pac. J. Cancer Prev. 2003, 4:215-224.
51. Subapriya R., Velmurugan B., Nagini S. Modulation of xenobiotic-metabolizing enzymes by ethanolic neem leaf extract during hamster buccal pouch carcinogenesis. J. Exp. Clin. Cancer Res. 2005, 24:223-230.
52. Subapriya R., Kumaraguruparan R., Nagini S. Expression of PCNA, cytokeratin, Bcl-2 and p53 during chemoprevention of hamster buccal pouch carcinogenesis by ethanolic neem (Azadirachta indica) leaf extract. Clin. Biochem. 2006, 39:1080-1087.
53. Sun S.-Y., Hail N., Lotan R. Apoptosis as a novel target for cancer chemoprevention. J. Natl Cancer Inst. 2004, 96:662-672.
54. Suresh G., Gopalakrishnan G., Wesley S.D., Pradeep Singh N., Malathi R., Rajan S. Insect antifeedant activity of tetranortriterpenoids from the Rutales. A perusal of structural relations. J. Agric. Food Chem. 2002, 50:4484-4490.
55. Surh Y.-J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 2003, 3:768-780.
56. Talalay P. Chemoprotection against cancer by induction of phase 2 enzymes. BioFactors 2000, 12:5-11.
57. Tepsuwan A., Kupradinun P., Kusamran W.R. Chemopreventive potential of neem flowers on carcinogen-induced rat mammary and liver carcinogenesis. Asian Pac. J. Cancer Prev. 2002, 3:231-238.
58. Thayyullathil F., Chathoth S., Hago A., Patel M., Galadari S. Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase-dependent and-independent apoptosis in L929 cells. Free Radical Biol. Med. 2008, 45:1403-1412.
59. Tsao A.S., Kim E.S., Hong W.K. Chemoprevention of cancer. CA Cancer J. Clin. 2004, 54:150-180.
60. Udeinya I., Mbah A., Chijioke C., Shu E. An antimalarial extract from neem leaves is antiretroviral. Trans. R. Soc. Trop. Med. Hyg. 2004, 98:435-437.
61. Vermeulen K., Van Bockstaele D.R., Berneman Z.N. Apoptosis: mechanisms and relevance in cancer. Ann. Hematol. 2005, 84:627-639.
62. Vinothini G., Manikandan P., Anandan R., Nagini S. Chemoprevention of rat mammary carcinogenesis by Azadirachta indica leaf fractions: modulation of hormone status, xenobiotic-metabolizing enzymes, oxidative stress, cell proliferation and apoptosis. Food Chem. Toxicol. 2009, 47:1852-1863.
63. Wattenberg L.W. Chemoprevention of cancer. Cancer Res. 1985, 45:1-8.
64. Wattenberg L.W. An overview of chemoprevention: current status and future prospects. Proc. Soc. Exp. Biol. Med. 1997, 216:133-141.